Doctor profile · Federal record
Dr. John Matthew Pierce, M.D.
Hematology & Oncology Physician (CMS: Internal Medicine) · Internal Medicine Physician · Birmingham, AL
- NPI 1669799961
- Accepts Medicare
- MIPS 78.7 / 100 · 2023
- 16 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
100 Pilot Medical Dr Ste 175
Birmingham, AL 35235
(205) 856-8488
Credentials & registration
- NPI registered
- April 2010 — 16 yrs on file
- Profile last updated
- April 8, 2019
- Year of graduation
- 2010 — 16 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Alabama #31405
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1669799961. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
70,423
Distinct HCPCS
10
Medicare allowed
$305,775
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 54,750 | 38 | $1 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 6,430 | 11 | $3 | |
J0897 |
Injection, denosumab, 1 mg | 3,960 | 17 | $23 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,148 | 28 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 1,010 | 26 | $1 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 760 | 244 | $8 | |
36415 |
Insertion of needle into vein for collection of blood sample | 631 | 228 | $8 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 327 | 170 | $82 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 248 | 102 | $111 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 190 | 44 | $107 |
In context: peer comparison
Among 34 peers in this city , average services per provider: 1,964. This provider delivers 36× the peer median.Open Payments
Industry payments received
All-time total
$2,974
Transactions
105
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $316.49 | |
| PFIZER INC. | 14 | $243.60 | |
| Merck Sharp & Dohme LLC | 8 | $180.50 | |
| Celgene Corporation | 8 | $178.61 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $151.01 | |
| Janssen Biotech, Inc. | 7 | $141.33 | |
| AstraZeneca Pharmaceuticals LP | 6 | $140.80 | |
| E.R. Squibb & Sons, L.L.C. | 10 | $137.52 | |
| Genentech USA, Inc. | 7 | $131.26 | |
| Alexion Pharmaceuticals, Inc. | 4 | $117.00 | |
| ABBVIE INC. | 5 | $104.45 | |
| Gilead Sciences, Inc. | 4 | $97.57 | |
| Astellas Pharma US Inc | 5 | $92.33 | |
| Incyte Corporation | 4 | $91.64 | |
| Tempus AI, Inc | 3 | $61.74 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,343
Patients
343
Total drug cost
$1,824,051
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Letrozole | Generic | 283 | 50 | $12,174 |
| Acyclovir | Generic | 226 | 39 | $7,287 |
| Tamoxifen Citrate | Generic | 120 | 24 | $3,653 |
| Ondansetron Hcl | Generic | 106 | 71 | $3,373 |
| Eliquis (Apixaban) | Brand | 79 | 12 | $47,526 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 69 | 32 | $1,588 |
| Gabapentin | Generic | 61 | 20 | $901 |
| Hydroxyurea | Generic | 61 | 11 | $2,633 |
| Revlimid (Lenalidomide) | Brand | 57 | 0 | $884,170 |
| Dexamethasone | Generic | 56 | 30 | $1,348 |
Frequently asked questions
What is Dr. John Matthew Pierce's medical specialty?
Dr. John Matthew Pierce practices Hematology & Oncology Physician in Birmingham, AL.
Where does Dr. John Matthew Pierce practice?
Dr. John Matthew Pierce practices at 100 Pilot Medical Dr Ste 175, Birmingham, AL 35235. Office phone: 2058568488.
What is Dr. John Matthew Pierce's NPI?
Dr. John Matthew Pierce's National Provider Identifier (NPI) is 1669799961, issued by NPPES.
Does Dr. John Matthew Pierce accept Medicare assignment?
Yes. Dr. John Matthew Pierce accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. John Matthew Pierce commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.